Personalized medicine is the future of health care
The foundation is in place, but we need more coordinated strategies to become the world leader in this field. Personalized medicine is the future of health care—a win-win for government, industry and Canadians.

More than 90 per cent of new pharmaceutical compounds don’t make it out of clinical trials. The stratospheric failure rate, plus the need for rigorous safety regulations, makes drug development expensive—more than $2.8-billion for each new drug, according to some research.
It’s small wonder t...
SPONSORED CONTENT
Get Weekend Point of View Newsletter
A round up of the past week’s opinion writers and columnists on Saturdays and Sundays.
By entering your email address you consent to receive email from The Hill Times containing news, analysis, updates and offers. You may unsubscribe at any time. See our privacy policy












